Pages that link to "Q54078500"
Jump to navigation
Jump to search
The following pages link to Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex. (Q54078500):
Displaying 50 items.
- Comparison of the antiviral activity of hydrophobic amino acid phosphoramidate monoesters of 2'3'-dideoxyadenosine (DDA) and 3'-azido-3'-deoxythymidine (AZT). (Q30660532) (← links)
- Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians (Q31975873) (← links)
- Relationship between didanosine exposure and surrogate marker response in human immunodeficiency virus-infected outpatients (Q33692547) (← links)
- Transplacental pharmacokinetics of dideoxyinosine in pigtailed macaques (Q33752846) (← links)
- Pharmacokinetics of dideoxyinosine in neonatal pigtailed macaques (Q33752888) (← links)
- Effect of antacids in didanosine tablet on bioavailability of isoniazid (Q33753738) (← links)
- Transport, metabolism and elimination mechanisms of anti-HIV agents (Q33933489) (← links)
- P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs (Q33933495) (← links)
- Development and optimization of anti-HIV nucleoside analogs and prodrugs: A review of their cellular pharmacology, structure-activity relationships and pharmacokinetics (Q33933498) (← links)
- Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators (Q33975889) (← links)
- Safety and pharmacokinetics of abacavir (1592U89) following oral administration of escalating single doses in human immunodeficiency virus type 1-infected adults (Q33976449) (← links)
- Lack of effect of simultaneously administered didanosine encapsulated enteric bead formulation (Videx EC) on oral absorption of indinavir, ketoconazole, or ciprofloxacin (Q34105081) (← links)
- Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis (Q34547322) (← links)
- Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis (Q34736674) (← links)
- Pharmacological and biological aspects of basic research on nucleoside-based reverse transcriptase inhibitors (Q35012107) (← links)
- Effect of zidovudine on transplacental pharmacokinetics of ddI in the pigtailed macaque (Macaca nemestrina). (Q35111463) (← links)
- Effect of fluconazole on pharmacokinetics of 2',3'-dideoxyinosine in persons seropositive for human immunodeficiency virus (Q35114198) (← links)
- Pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) in the neonatal macaque (Macaca nemestrina). (Q35121223) (← links)
- In vitro potency of inhibition by antiviral drugs of hematopoietic progenitor colony formation correlates with exposure at hemotoxic levels in human immunodeficiency virus-positive humans. (Q35122740) (← links)
- Didanosine measurement by radioimmunoassay (Q35124724) (← links)
- Prenatal and postpartum pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) and didanosine (dideoxyinosine) in pigtailed macaques (Macaca nemestrina) (Q35128529) (← links)
- Update on didanosine (Q35207285) (← links)
- Didanosine (Q35255870) (← links)
- Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection (Q35331251) (← links)
- Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trials (Q35862757) (← links)
- Lack of pharmacokinetic interaction between intravenous 2',3'-dideoxyinosine and 3'-azido-3'-deoxythymidine in rats (Q35867338) (← links)
- Pharmacokinetics of antiretrovirals in pregnant women (Q35965780) (← links)
- Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infection (Q36097686) (← links)
- Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions (Q36342389) (← links)
- Permeation of four oral drugs through human intestinal mucosa (Q37146194) (← links)
- Didanosine population pharmacokinetics in West African human immunodeficiency virus-infected children administered once-daily tablets in relation to efficacy after one year of treatment (Q37392730) (← links)
- Pharmacokinetic-interaction study of didanosine and ranitidine in patients seropositive for human immunodeficiency virus (Q40088469) (← links)
- Computational models to assign biopharmaceutics drug disposition classification from molecular structure (Q40175522) (← links)
- Pharmacokinetic Optimisation of Antiretroviral Therapy in Patients with HIV Infection (Q40430974) (← links)
- Antiviral therapy in human immunodeficiency virus infections. Current status (Part II). (Q40487963) (← links)
- Management of antiretroviral drug therapy in human immunodeficiency virus infection (Q40626125) (← links)
- Lamivudine (3TC) phosphorylation and drug interactions in vitro (Q40880707) (← links)
- Comparative pharmacokinetics of antiviral nucleoside analogues (Q40886850) (← links)
- Effects of zidovudine (AZT) and dideoxyinosine (ddI) on human trophoblast cells (Q40909668) (← links)
- Chemotherapeutic agents for human immunodeficiency virus infection: mechanism of action, pharmacokinetics, metabolism, and adverse reactions (Q41729315) (← links)
- Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection (Q42281858) (← links)
- Effect of time of food administration on the bioavailability of didanosine from a chewable tablet formulation (Q42614912) (← links)
- Absence of clinically relevant drug interactions following simultaneous administration of didanosine-encapsulated, enteric-coated bead formulation with either itraconazole or fluconazole (Q42673742) (← links)
- Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome. (Q43201730) (← links)
- Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography. (Q44456583) (← links)
- Determination of carrier-mediated transport of 2',3'-dideoxypurine nucleosides in the rat ileum using a bidirectional perfusion technique (Q44806122) (← links)
- Phase I dose-escalation pharmacokinetics of AZT-P-ddI (IVX-E-59) in patients with human immunodeficiency virus (Q45763995) (← links)
- Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus (Q45777843) (← links)
- Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine (Q46807623) (← links)
- Physiologically based pharmacokinetic models of 2',3'-dideoxyinosine (Q48784143) (← links)